The file's text, extracted by GovTribe without its formatting.
Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice
| SUBJECT* |
| NTX Blood & Blood Products |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 78240 |
| SOLICITATION NUMBER* |
| 36C25722Q0049 |
| RESPONSE DATE/TIME/ZONE |
| 12-03-2021 15:00 EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 90 DAYS AFTER THE RESPONSE DATE |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6505 |
CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs VISN17 Network Contracting Activity 5441 Babcock Road Ste. 302 San Antonio TX 78240
POINT OF CONTACT*
Contract Specialist Delphia Schoenfeld delphia.schoenfeld@va.gov 210-694-6336
PLACE OF PERFORMANCE
| ADDRESS |
| Department of Veterans Affairs |
VA North Texas Healthcare System
Laboratory
4500 S. Lancaster Rd.
Dallas TX
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
DESCRIPTION
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number 36C25722Q0049 is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2021-07.
The NAICS Code for this request for quotes is 621991 ($35.0 million). No set-aside is used for this solicitation.
The items being requested are as follows:
| ITEM NUMBER |
| DESCRIPTION OF SUPPLIES/ SERVICES |
| QUANTITY |
| UNIT |
| 0001 |
| Red Cells, Leukocyte reduced (LRBC) |
HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0001AA |
| Red Cells, LRBC - O+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0001AB |
| Red Cells, LRBC - O- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0001AC |
| Red Cells, LRBC - A+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0001AD |
| Red Cells, LRBC - A- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0001AE |
| Red Cells, LRBC - B+ |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0001AF |
| Red Cells, LRBC - B- |
Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 1 POP Begin: 03-01-2022 POP End: 02-28-2023
| 0001AG |
| Red Cells, LRBC - AB+ |
Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0002 |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0002AA |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0002AB |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0003 |
| Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) |
HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0004 |
| Cryoprecipitate, frozen pooled from 5 donors (PCRYO) |
HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0005 |
| Platelet-pheresis, HLA matched |
HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0006 |
| Deglycerolyzed Red cells |
HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0007 |
| HLA Computer match fee |
CPT: 86828
Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0008 |
| Freezing of Patient RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0009 |
| Deglycerolization of frozen RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
CPT: NA
Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0011 |
| Autologous Donor Fee |
CPT: 86890
Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
CPT: 86945
Estimated Annual Qty: 700 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
CPT: 86023
Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0014 |
| Platelet Antibody Screen |
CPT: 86022
Estimated Annual Qty: 3 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0015 |
| Red Blood Cells Washed |
CPT: NA
Estimated Annual Qty: 3 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0016 |
| Antigen Screen, Tier 1 antigen (C, c, E, or K) |
CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0017 |
| Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0018 |
| Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0022 |
| Frozen Blood Storage (up to 90 days) |
CPT Code: NA Estimated Annual Qty: 3 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0023 |
| Imported Rare Unit Fee |
CPT Code: NA Estimated Annual Qty: 4 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0024 |
| Molecular Phenotyping |
CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0025 |
| Therapeutic Phlebotomy Donation |
CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 0026 |
| Therapeutic Phlebotomy Donation (eligible for recipients) |
CPT Code: NA Estimated Annual Qty: 60 Pricing Period 1 POP Begin: 03-02-2022 POP End: 03-01-2023
| 1001 |
| Red Cells, Leukocyte reduced (LRBC) |
HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1001AA |
| Red Cells, LRBC - O+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1001AB |
| Red Cells, LRBC - O- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1001AC |
| Red Cells, LRBC - A+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1001AD |
| Red Cells, LRBC - A- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1001AE |
| Red Cells, LRBC - B+ |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1001AF |
| Red Cells, LRBC - B- |
Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1001AG |
| Red Cells, LRBC - AB+ |
Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1002 |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1002AA |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1002AB |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1003 |
| Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) |
HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1004 |
| Cryoprecipitate, frozen pooled from 5 donors (PCRYO) |
HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1005 |
| Platelet-pheresis, HLA matched |
HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1006 |
| Deglycerolyzed Red cells |
HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1007 |
| HLA Computer match fee |
CPT: 86828
Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1008 |
| Freezing of Patient RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1009 |
| Deglycerolization of frozen RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
CPT: NA
Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1011 |
| Autologous Donor Fee |
CPT: 86890
Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
CPT: 86945
Estimated Annual Qty: 700 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
CPT: 86023
Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1014 |
| Platelet Antibody Screen |
CPT: 86022
Estimated Annual Qty: 3 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1015 |
| Red Blood Cells Washed |
CPT: NA
Estimated Annual Qty: 3 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1016 |
| Antigen Screen, Tier 1 antigen (C, c, E, or K) |
CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1017 |
| Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1018 |
| Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1022 |
| Frozen Blood Storage (up to 90 days) |
CPT Code: NA Estimated Annual Qty: 3 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1023 |
| Imported Rare Unit Fee |
CPT Code: NA Estimated Annual Qty: 4 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1024 |
| Molecular Phenotyping |
CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1025 |
| Therapeutic Phlebotomy Donation |
CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 1026 |
| Therapeutic Phlebotomy Donation (eligible for recipients) |
CPT Code: NA Estimated Annual Qty: 60 Pricing Period 2 POP Begin: 03-02-2023 POP End: 03-01-2024
| 2001 |
| Red Cells, Leukocyte reduced (LRBC) |
HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2001AA |
| Red Cells, LRBC - O+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2001AB |
| Red Cells, LRBC - O- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2001AC |
| Red Cells, LRBC - A+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2001AD |
| Red Cells, LRBC - A- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2001AE |
| Red Cells, LRBC - B+ |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2001AF |
| Red Cells, LRBC - B- |
Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2001AG |
| Red Cells, LRBC - AB+ |
Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2002 |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2002AA |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2002AB |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2003 |
| Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) |
HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2004 |
| Cryoprecipitate, frozen pooled from 5 donors (PCRYO) |
HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2005 |
| Platelet-pheresis, HLA matched |
HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2006 |
| Deglycerolyzed Red cells |
HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2007 |
| HLA Computer match fee |
CPT: 86828
Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2008 |
| Freezing of Patient RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2009 |
| Deglycerolization of frozen RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
CPT: NA
Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2011 |
| Autologous Donor Fee |
CPT: 86890
Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
CPT: 86945
Estimated Annual Qty: 700 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
CPT: 86023
Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2014 |
| Platelet Antibody Screen |
CPT: 86022
Estimated Annual Qty: 3 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2015 |
| Red Blood Cells Washed |
CPT: NA
Estimated Annual Qty: 3 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2016 |
| Antigen Screen, Tier 1 antigen (C, c, E, or K) |
CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2017 |
| Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2018 |
| Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2022 |
| Frozen Blood Storage (up to 90 days) |
CPT Code: NA Estimated Annual Qty: 3 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2023 |
| Imported Rare Unit Fee |
CPT Code: NA Estimated Annual Qty: 4 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2024 |
| Molecular Phenotyping |
CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2025 |
| Therapeutic Phlebotomy Donation |
CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 2026 |
| Therapeutic Phlebotomy Donation (eligible for recipients) |
CPT Code: NA Estimated Annual Qty: 60 Pricing Period 3 POP Begin: 03-02-2024 POP End: 03-01-2025
| 3001 |
| Red Cells, Leukocyte reduced (LRBC) |
HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3001AA |
| Red Cells, LRBC - O+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3001AB |
| Red Cells, LRBC - O- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3001AC |
| Red Cells, LRBC - A+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3001AD |
| Red Cells, LRBC - A- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3001AE |
| Red Cells, LRBC - B+ |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3001AF |
| Red Cells, LRBC - B- |
Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3001AG |
| Red Cells, LRBC - AB+ |
Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3002 |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3002AA |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3002AB |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3003 |
| Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) |
HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3004 |
| Cryoprecipitate, frozen pooled from 5 donors (PCRYO) |
HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3005 |
| Platelet-pheresis, HLA matched |
HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3006 |
| Deglycerolyzed Red cells |
HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3007 |
| HLA Computer match fee |
CPT: 86828
Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3008 |
| Freezing of Patient RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3009 |
| Deglycerolization of frozen RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
CPT: NA
Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3011 |
| Autologous Donor Fee |
CPT: 86890
Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
CPT: 86945
Estimated Annual Qty: 700 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
CPT: 86023
Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3014 |
| Platelet Antibody Screen |
CPT: 86022
Estimated Annual Qty: 3 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3015 |
| Red Blood Cells Washed |
CPT: NA
Estimated Annual Qty: 3 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3016 |
| Antigen Screen, Tier 1 antigen (C, c, E, or K) |
CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3017 |
| Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3018 |
| Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3022 |
| Frozen Blood Storage (up to 90 days) |
CPT Code: NA Estimated Annual Qty: 3 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3023 |
| Imported Rare Unit Fee |
CPT Code: NA Estimated Annual Qty: 4 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3024 |
| Molecular Phenotyping |
CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3025 |
| Therapeutic Phlebotomy Donation |
CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 3026 |
| Therapeutic Phlebotomy Donation (eligible for recipients) |
CPT Code: NA Estimated Annual Qty: 60 Pricing Period 4 POP Begin: 03-02-2025 POP End: 03-01-2026
| 4001 |
| Red Cells, Leukocyte reduced (LRBC) |
HCPCS Code: P9016 Estimated Annual Qty: 4,500 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4001AA |
| Red Cells, LRBC - O+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4001AB |
| Red Cells, LRBC - O- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4001AC |
| Red Cells, LRBC - A+ |
Estimated Weekly Qty: 30 Estimated Annual Qty: 1560 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4001AD |
| Red Cells, LRBC - A- |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4001AE |
| Red Cells, LRBC - B+ |
Estimated Weekly Qty: 10 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4001AF |
| Red Cells, LRBC - B- |
Estimated Weekly Qty: 5 Estimated Annual Qty: 260 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4001AG |
| Red Cells, LRBC - AB+ |
Estimated Weekly Qty: 0 Estimated Annual Qty: 0 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4002 |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
HCPCS Code: P9035 Estimated Annual Qty: 520 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4002AA |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
O+ or O- Estimated Weekly Qty: 6 Estimated Annual Qty: 312 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4002AB |
| Platelets, Pheresis, Leukocyte reduced (LPPLT) |
A+ or A- Estimated Weekly Qty: 4 Estimated Annual Qty: 208 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4003 |
| Fresh frozen plasma, OR Plasma frozen <24 hours (FFP or PF24) |
HCPCS Code: P9017 or P9059 Estimated Annual Qty: 350 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4004 |
| Cryoprecipitate, frozen pooled from 5 donors (PCRYO) |
HCPCS Code: P9012x5 Estimated Annual Qty: 150 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4005 |
| Platelet-pheresis, HLA matched |
HCPCS Code: P9035 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4006 |
| Deglycerolyzed Red cells |
HCPCS Code: P9054 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4007 |
| HLA Computer match fee |
CPT: 86828
Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4008 |
| Freezing of Patient RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4009 |
| Deglycerolization of frozen RBC |
CPT: NA
Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
CPT: NA
Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4011 |
| Autologous Donor Fee |
CPT: 86890
Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
CPT: 86945
Estimated Annual Qty: 700 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
CPT: 86023
Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4014 |
| Platelet Antibody Screen |
CPT: 86022
Estimated Annual Qty: 3 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4015 |
| Red Blood Cells Washed |
CPT: NA
Estimated Annual Qty: 3 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4016 |
| Antigen Screen, Tier 1 antigen (C, c, E, or K) |
CPT Code: 86905 Estimated Annual Qty: 30 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4017 |
| Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4018 |
| Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) |
CPT Code: 86905 Estimated Annual Qty: 50 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
CPT Code: 86900 and 86901 Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
CPT Code: 86644 Estimated Annual Qty: 5 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
CPT Code: 86870 Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4022 |
| Frozen Blood Storage (up to 90 days) |
CPT Code: NA Estimated Annual Qty: 3 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4023 |
| Imported Rare Unit Fee |
CPT Code: NA Estimated Annual Qty: 4 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4024 |
| Molecular Phenotyping |
CPT Code: 81403 Estimated Annual Qty: 10 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4025 |
| Therapeutic Phlebotomy Donation |
CPT Code: 99195 Estimated Annual Qty: 70 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
| 4026 |
| Therapeutic Phlebotomy Donation (eligible for recipients) |
CPT Code: NA Estimated Annual Qty: 60 Pricing Period 5 POP Begin: 03-02-2026 POP End: 03-01-2027
The services being requested are for the reference laboratory testing of patient specimen. Services are to be performed at the VA North Texas Healthcare System, Laboratory, 4500 S. Lancaster Rd., Dallas, TX 75216.
The provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition.
The provision at 52.212-2, Evaluation-Commercial Items, applies to this acquisition. The evaluation criteria are technical acceptability, past performance, price. Under technical includes the ability to provide all of the requested items in accordance with the Statement of Work, provide a letter of authorization (if not the manufacturer) and a description of equal items, and have, at minimum, a “Satisfactory” past performance rating.
Offerors are to provide a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer.
The clause at 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. There are no addenda to this clause.
The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. The following clauses cited in this clause are applicable:
1. FAR 52.203-6 Restrictions on Subcontractor Sales to the Government (JUN 2020), with Alternate I (OCT 1995)
2. FAR 52.203-13 Contractor Code of Business Ethics and Conduct (JUN 2020)
3. FAR 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017)
4. FAR 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards (JUN 2020)
5. FAR 52.204–23 Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (JUL 2018)
6. FAR 52.204–25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (AUG 2019)
7. FAR 52.209-6 Protecting the Government’s Interest when Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment (JUN 2020)
8. FAR 52.209-9 Updates of Publicly Available Information Regarding Responsibility Matters (OCT 2018)
9. FAR 52.209-10 Prohibition on Contracting with Inverted Domestic Corporations (NOV 2015)
10. FAR 52.219-8 Utilization of Small Business Concerns (OCT 2018)
11. FAR 52.219-9 Small Business Subcontracting Plan (JUN 2020)
12. FAR 52.219-28 Post Award Small Business Program Rerepresentation (NOV 2020)
13. FAR 52.222-3 Convict Labor (JUN 2003)
14. FAR 52.222-21 Prohibition of Segregated Facilities (APR 2015)
15. FAR 52.222–26 Equal Opportunity (SEP 2016)
16. FAR 52.222-35 Equal Opportunity for Veterans (JUN 2020)
17. FAR 52.222-36 Equal Opportunity for Workers with Disabilities (JUN 2020)
18. FAR 52.222-37 Employment Reports on Veterans (JUN 2020)
19. FAR 52.222-50 Combating Trafficking in Persons (JAN 2019)
20. FAR 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving (JUN 2020)
21. FAR 52.225-5 Trade Agreements (JUL 2020) Deviation
22. FAR 52.225-13 Restrictions on Certain Foreign Purchases (JUN 2008)
23. FAR 52.229-12 Tax on Certain Foreign Procurements (JUN 2020)
24. FAR 52.232-33 Payment by Electronic Funds Transfer—System for Award Management (Oct 2018)
25. FAR 52.242-5 Payments to Small Business Contractors (JAN 2017)
Additional Terms and Conditions:
1. FAR 52.203-17 Contractor Employee Whistleblower Rights and Requirement to Inform Employees of Whistleblower Rights (JUN 2020)
2. Far 52.204-4 Printed or Copied Double-Sided on Post-Consumer Fiber Content Paper (MAY 2011)
3. FAR 52.204-13 System for Award Management Maintenance (Oct 2018)
4. FAR 52.204-18 Commercial and Government Entity Code Maintenance (JUL 2016)
5. FAR 52.216-18 Ordering (AUG 2020)
6. FAR 52.216-19 Order Limitations (OCT 1995)
7. FAR 52.216-22 Indefinite Quantity (OCT 1995)
8. FAR 52.217-8 Option to Extend Services (NOV 1999)
9. FAR 52.223-99 Ensuring Adequate COVID-19 Safety Protocols for Federal Contractors (OCT 2021) (Deviation)
10. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (DEC 2013)
11. FAR 52.317-3 Continuity of Services (JAN 1991)
12. VAAR 852.212-70 Provisions and Clauses Applicable to VA Acquisition of Commercial Items (APR 2020)
a. VAAR 852.203–70 Commercial Advertising
b. VAAR 852.219-9 VA Small Business Subcontracting Plan Minimum Requirements
c. VAAR 852.232–72 Electronic Submission of Payment Requests
d. VAAR 852.233-70 Protest Content/ Alternative Dispute Resolution
e. VAAR 852.233-71 Alternate Protest Procedure
f. VAAR 852.246-71 Rejected Goods
g. VAAR 852.246-73 Noncompliance with Packaging, Packing, and/or Marking Requirements
h. VAAR 852.270–1 Representatives of Contracting Officers
i. VAAR 852.273–70 Late Offers
13. VAAR 852.212-71 Gray Market Items
14. VAAR 852.219-71 VA Mentor-Protégé Program (DEC 2009)
15. VAAR 852.219-72 Evaluation Factor for Participation in the VA Mentor-Protégé Program (DEC 2009)
16. VAAR 852.219-75 Subcontracting Commitments Monitoring and Compliance (JUL 2018)
17. VAAR 852.219-76 Subcontracting Plans Monitoring and Compliance (JUL 2018)
18. VAAR 852.242-71 Administrative Contracting Officer (OCT 2020)
19. VAAR 852.247-73 Packing for Domestic Shipment (OCT 2018)
Additional Provisions:
1. FAR 52.204-7 System for Award Management (OCT 2018)
2. FAR 52.204-16 Commercial and Government Entity Code Reporting (AUG 2020)
3. FAR 52.204-24 Representation Regarding Telecommunications and Video Surveillance Services or Equipment (AUG 2019)
4. FAR 52.209-7 Information Regarding Responsibility Matters (OCT 2018)
5. FAR 52.229-11 Tax on Certain Foreign Procurements – Notice and Representation (JUN 2020)
6. FAR 52.233-2 Service of Protest (SEP 2006)
7. VAAR 852.215-72 Notice of Intent to Re-Solicit (OCT 2019)
Please submit all required documentation to Delphia Schoenfeld at delphia.schoenfeld@va.gov, no later than December 3, 2021, 3 PM ET (2 PM CT).
See attached document: RFQ 36C25722Q0049.
| *= Required Field |
| Combined Synopsis/Solicitation Notice |
Combined Synopsis/Solicitation Notice
